Alivus Life Sciences (NSE:ALIVUS) Receivables Turnover : 0.83 (As of Dec. 2024)

View and export this data going back to 2021. Start your Free Trial

What is Alivus Life Sciences Receivables Turnover?

The Receivables Turnover ratio measures the number of times a company collects its average accounts receivable balance. It is calculated as Revenue divided by average Accounts Receivable. An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. Alivus Life Sciences's Revenue for the three months ended in Dec. 2024 was ₹6,418 Mil. Alivus Life Sciences's average Accounts Receivable for the three months ended in Dec. 2024 was ₹7,751 Mil. Hence, Alivus Life Sciences's Receivables Turnover for the three months ended in Dec. 2024 was 0.83.

Alivus Life Sciences Receivables Turnover Historical Data

The historical data trend for Alivus Life Sciences's Receivables Turnover can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Alivus Life Sciences Receivables Turnover Chart

Alivus Life Sciences Annual Data

Trend

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Receivables Turnover

Get a 7-Day Free Trial

2.75

2.96

3.23

2.77

2.78

Alivus Life Sciences Quarterly Data
	Mar19	Mar20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Receivables Turnover	Get a 7-Day Free Trial															0.71	0.57	0.77	0.65	0.83

Competitive Comparison of Alivus Life Sciences's Receivables Turnover

For the Drug Manufacturers - Specialty & Generic subindustry, Alivus Life Sciences's Receivables Turnover, along with its competitors' market caps and Receivables Turnover data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Alivus Life Sciences's Receivables Turnover Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Alivus Life Sciences's Receivables Turnover distribution charts can be found below:

* The bar in red indicates where Alivus Life Sciences's Receivables Turnover falls into.

Save Embed

;

Save Embed

;

Alivus Life Sciences Receivables Turnover Calculation

Receivables Turnover measures the number of times a company collects its average accounts receivable balance.

Alivus Life Sciences's Receivables Turnover for the fiscal year that ended in Mar. 2024 is calculated as

	Receivables Turnover (A: Mar. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (A: Mar. 2024 )	/ (	(Accounts Receivable (A: Mar. 2023 )	+	Accounts Receivable (A: Mar. 2024 ))	/	count )
=	21847.7	/ (	(8067.66	+	7654.32)	/	2 )
=	21847.7	/	7860.99
=	2.78

Alivus Life Sciences's Receivables Turnover for the quarter that ended in Dec. 2024 is calculated as

	Receivables Turnover (Q: Dec. 2024 )
=	Revenue	/	Average Total Inventories
=	Revenue (Q: Dec. 2024 )	/ (	(Accounts Receivable (Q: Sep. 2024 )	+	Accounts Receivable (Q: Dec. 2024 ))	/	count )
=	6418.44	/ (	(7751.27	+	0)	/	1 )
=	6418.44	/	7751.27
=	0.83

Alivus Life Sciences (NSE:ALIVUS) Receivables Turnover Explanation

An efficient company has a higher accounts receivable turnover ratio while an inefficient company has a lower ratio. This metric is commonly used to compare companies within the same industry to check whether they are on par with their competitors.

Alivus Life Sciences Receivables Turnover Related Terms

Thank you for viewing the detailed overview of Alivus Life Sciences's Receivables Turnover provided by GuruFocus.com. Please click on the following links to see related term pages.

Alivus Life Sciences Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Alivus Life Sciences Ltd (NSE:ALIVUS) » Definitions » Receivables Turnover

Traded in Other Exchanges

543322:India

Address

470, Cardinal Gracious Road, 4th Floor, OIA House, Andheri (East), Mumbai, MH, IND, 400 099

Website

https://www.alivus.com

Alivus Life Sciences Ltd, formerly Glenmark Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disease, pain management, diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas.

Alivus Life Sciences Headlines

No Headlines